omega-n-methylarginine has been researched along with Angiogenesis, Pathologic in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 7 (77.78) | 18.2507 |
| 2000's | 2 (22.22) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Buerk, DG; Demou, ZN; Fukumura, D; Gohongi, T; Huang, PL; Izumi, Y; Jain, RK; Kashiwagi, S; Munn, LL; Xu, L | 1 |
| Fong, TW; Harlow, LA; Koch, AE; Leibovich, SJ; Polverini, PJ | 1 |
| Andriopoulou, P; Haralabopoulos, G; Maragoudakis, ME; Peristeris, P; Pipili-Synetos, E; Sakkoula, E | 1 |
| Bult, H; De Meyer, GR; Herman, AG; Jordaens, FH; Kockx, M; Ustünes, L; Zonnekeyn, LL | 1 |
| Cambria, RA; Gloviczki, P; Lowell, RC; Miller, VM | 1 |
| Fukuo, K; Inoue, T; Kitano, S; Morimoto, S; Nakahashi, T; Ogihara, T; Sasada, R; Yasuda, O | 1 |
| Ader, JL; Jonca, F; Malavaud, B; Moro, F; Plouët, J; Praddaude, F; Tack, I | 1 |
| Batten, JJ; Kakkar, AK; Mathie, RT; Sirivatanauksorn, Y; Thamrongwittawatpong, L; Williamson, RC | 1 |
| Andrade, SP; Hart, IR; Piper, PJ | 1 |
9 other study(ies) available for omega-n-methylarginine and Angiogenesis, Pathologic
| Article | Year |
|---|---|
NO mediates mural cell recruitment and vessel morphogenesis in murine melanomas and tissue-engineered blood vessels.
Topics: Animals; Cells, Cultured; Endothelial Cells; Enzyme Inhibitors; Gene Expression; Humans; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, SCID; Neovascularization, Pathologic; Neovascularization, Physiologic; Nitric Oxide; Nitric Oxide Synthase; omega-N-Methylarginine; Tissue Engineering | 2005 |
Production of angiogenic activity by human monocytes requires an L-arginine/nitric oxide-synthase-dependent effector mechanism.
Topics: Amino Acid Oxidoreductases; Animals; Arginine; Cells, Cultured; Chemotaxis; Cornea; Culture Media, Conditioned; Endothelium, Vascular; Endotoxins; Humans; Interleukin-8; Lipopolysaccharides; Monocytes; Neovascularization, Pathologic; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; omega-N-Methylarginine; Rats; Stereoisomerism; Tumor Necrosis Factor-alpha; Umbilical Veins | 1994 |
Evidence that nitric oxide is an endogenous antiangiogenic mediator.
Topics: Allantois; Animals; Arginine; Chick Embryo; Chorion; Cyclic GMP; Dexamethasone; Drug Interactions; Endothelium, Vascular; Humans; Models, Biological; Neovascularization, Pathologic; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitroprusside; omega-N-Methylarginine; Superoxide Dismutase; Tetradecanoylphorbol Acetate; Thrombin | 1994 |
Vasoconstrictor responses after neo-intima formation and endothelial removal in the rabbit carotid artery.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Angiotensin I; Angiotensin II; Animals; Arginine; Carotid Arteries; Endothelium, Vascular; In Vitro Techniques; Male; Muscle Contraction; Muscle, Smooth, Vascular; Neovascularization, Pathologic; Nitric Oxide; Nitroarginine; omega-N-Methylarginine; Potassium Chloride; Prostaglandin Endoperoxides, Synthetic; Rabbits; Serotonin; Thromboxane A2; Vasoconstriction; Vasoconstrictor Agents | 1994 |
Chronic changes in blood flow alter endothelium-dependent responses in autogenous vein grafts in dogs.
Topics: Acetylcholine; Adenosine Diphosphate; Adrenergic alpha-Agonists; Animals; Arginine; Arteriovenous Shunt, Surgical; Blood Flow Velocity; Brimonidine Tartrate; Calcimycin; Constriction; Dinoprost; Dogs; Endothelins; Endothelium, Vascular; Femoral Artery; Femoral Vein; Hyperplasia; Male; Models, Biological; Neovascularization, Pathologic; Nitric Oxide; omega-N-Methylarginine; Quinoxalines; Thrombin; Tunica Intima; Vascular Patency | 1994 |
Nitric oxide mediates cytotoxicity and basic fibroblast growth factor release in cultured vascular smooth muscle cells. A possible mechanism of neovascularization in atherosclerotic plaques.
Topics: Animals; Aorta; Aorta, Thoracic; Arginine; Arteriosclerosis; Cattle; Cell Division; Cells, Cultured; DNA; Endothelium, Vascular; Fibroblast Growth Factor 2; Immunohistochemistry; Interleukin-1; Kinetics; L-Lactate Dehydrogenase; Muscle, Smooth, Vascular; Neovascularization, Pathologic; Nitric Oxide; Nitroprusside; omega-N-Methylarginine; Rats; Rats, Wistar | 1995 |
Activation of Flk-1/KDR mediates angiogenesis but not hypotension.
Topics: Animals; Antibodies, Anti-Idiotypic; Blood Pressure; Cornea; Dose-Response Relationship, Drug; Endothelial Growth Factors; Lymphokines; Male; Neovascularization, Pathologic; omega-N-Methylarginine; Rabbits; Rats; Rats, Inbred WKY; Receptor Protein-Tyrosine Kinases; Receptors, Growth Factor; Receptors, Vascular Endothelial Growth Factor; Statistics, Nonparametric; Time Factors; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors | 1997 |
The effect of N(G)-monomethyl-L-arginine and tamoxifen on nitric oxide production in breast cancer cells stimulated by oestrogen and progesterone.
Topics: Antineoplastic Agents, Hormonal; Breast Neoplasms; Enzyme Inhibitors; Estrogens; Female; Humans; Neovascularization, Pathologic; Nitric Oxide; omega-N-Methylarginine; Progesterone; Tamoxifen; Tumor Cells, Cultured | 2001 |
Inhibitors of nitric oxide synthase selectively reduce flow in tumor-associated neovasculature.
Topics: Adenocarcinoma; Amino Acid Oxidoreductases; Animals; Arginine; Colonic Neoplasms; Male; Melanoma, Experimental; Methylene Blue; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Neoplasm Transplantation; Neoplasms, Experimental; Neovascularization, Pathologic; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; omega-N-Methylarginine; Prostheses and Implants; Regional Blood Flow | 1992 |